ECSP982684A - MEDICINES - Google Patents

MEDICINES

Info

Publication number
ECSP982684A
ECSP982684A ECSP982684A ECSP982684A EC SP982684 A ECSP982684 A EC SP982684A EC SP982684 A ECSP982684 A EC SP982684A EC SP982684 A ECSP982684 A EC SP982684A
Authority
EC
Ecuador
Prior art keywords
medicines
unconstipated
ibs
treatment
relates
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Allen Wayne Mangel
Allison Ruth Northcutt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP982684 priority Critical patent/ECSP982684A/en
Publication of ECSP982684A publication Critical patent/ECSP982684A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere al uso de un antagonista del receptor de 5-HT3, en el tratamiento de pacientes femeninos con IBS no constipados.The present invention relates to the use of a 5-HT3 receptor antagonist, in the treatment of female patients with unconstipated IBS.

ECSP982684 1998-10-05 1998-10-05 MEDICINES ECSP982684A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP982684 ECSP982684A (en) 1998-10-05 1998-10-05 MEDICINES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP982684 ECSP982684A (en) 1998-10-05 1998-10-05 MEDICINES

Publications (1)

Publication Number Publication Date
ECSP982684A true ECSP982684A (en) 1999-04-13

Family

ID=42043603

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP982684 ECSP982684A (en) 1998-10-05 1998-10-05 MEDICINES

Country Status (1)

Country Link
EC (1) ECSP982684A (en)

Similar Documents

Publication Publication Date Title
HN1998000155A (en) MEDICINES
PT1326643E (en) INHIBITION OF THE EMETIC EFFECT OF METFORMIN WITH 5-HT3 RECEPTOR ANTAGONISTS
IS6750A (en) Synchronous heterocyclic succinimide compounds and their analogues, configured for nuclear hormone receptor activity
TR200200951T2 (en) Pharmaceutical compositions
ECSP034540A (en) CRYSTALLINE MONOHIDRATE, PROCEDURE FOR ITS PREPARATION AND ITS USE FOR THE PREPARATION OF A MEDICINAL PRODUCT
FI960727A0 (en) Heterocycles useful as neurokinin antagonists
AR037109A1 (en) USE OF FLIBANSERINE
BR0308429A (en) Monocyclic Aroylpyridinones as Anti-Inflammatory Agents
MA29369B1 (en) FIXED ASSAY OF ANTI-HER ANTIBODIES
EA200101046A1 (en) INDIVIDUAL BIS-INDOL DERIVATIVES
CY1110878T1 (en) PROCEDURES FOR MEASURING THE POWER OF GLATIRAMER ACETATE
BR9911621A (en) Biphenyl sulfonamides as dual angiotensin receptor endothelin antagonist
AU5984801A (en) Local anesthetic methods and kits
TR200101719T2 (en) The use of apomorphine in drug manufacture for the treatment of organic erectile dysfunction in men
BRPI0311189B8 (en) pharmaceutical compositions containing flibanserin polymorph a, as well as its use
HUP9800938A2 (en) Nk-1 receptor antagonists for the treatment of symptoms of irritable bowel syndrome
EA200500213A1 (en) DISPENSABLE TABLETS FOR ORAL APPOINTMENT
NO983177L (en) Use of the 1-enantiomer of centroman for the preparation of a pharmaceutical composition for the treatment or prophylaxis of breast cancer
EE05241B1 (en) Use of the α-halogenoacryl derivative of distamycin
MXPA05008906A (en) 2-substituted estra-1,3,5(10)-triene-3-yl sulfamate with an anti-tumour action.
CY1109803T1 (en) PHARMACEUTICAL COMPOSITES BASED ON NK2 COMPONENTS FOR PEDIATRIC USE
EA200501565A1 (en) INTENDED FOR ORAL ADMINISTRATION MEDICINE FORM FOR PROTONE PUMP ANTAGONISTS
PE20011080A1 (en) USE OF MIRTAZAPINE FOR THE TREATMENT OF SLEEP DISORDERS
ECSP982684A (en) MEDICINES
EA200100802A1 (en) APPLICATION OF TIANEPTIN IN THE PREPARATION OF MEDICINES INTENDED FOR THE TREATMENT OF NEURODEGENERATIVE PATHOLOGIES